Determination of HIV-1 Chemokine Coreceptor Tropism Using Transduced Human Osteosarcoma (HOS) Cells.

Area of Science:

• Immunology
• Virology
• Genetics

Background:

• CD4 was identified as the primary receptor for Human Immunodeficiency Virus type 1 (HIV-1) in 1984.
• HIV-1 infection necessitates a second receptor, or coreceptor, on CD4+ cells.
• Chemokine receptors, specifically CXCR4 and CCR5, were identified as key HIV-1 coreceptors.

Purpose of the Study:

• To elucidate the role of chemokine coreceptors in HIV-1 cell entry.
• To understand the differential usage of CCR5 and CXCR4 by various HIV-1 strains.
• To explore the impact of chemokine coreceptor genetics on HIV-1 infection and disease progression.

Main Methods:

• Identification of chemokine receptors mediating HIV-1 fusion and entry.
• Characterization of HIV-1 strains based on coreceptor usage (R5, X4, X4R5).
• Analysis of CCR5 gene polymorphisms (e.g., 32-bp deletion) and their association with HIV-1 infection and disease.

Main Results:

• T-cell line-adapted HIV-1 strains utilize CXCR4 (fusin).
• Macrophage-tropic HIV-1 isolates utilize CCR5.
• Individuals with CCR5 gene deletions show reduced HIV-1 susceptibility and slower disease progression.

Conclusions:

• HIV-1 entry into CD4+ cells depends on both CD4 and specific chemokine coreceptors (CCR5, CXCR4).
• Coreceptor tropism (R5, X4, dual) dictates the cellular targets and disease characteristics of HIV-1 infection.
• Genetic variations in CCR5 offer natural resistance and influence disease outcomes in HIV-1-infected individuals.